Human Laboratory Study of the Effects of Nicotine Product Claims on Appeal, Perceptions, and Use Behavior
Launched by OHIO STATE UNIVERSITY COMPREHENSIVE CANCER CENTER · Jan 3, 2024
Trial Information
Current as of July 09, 2025
Recruiting
Keywords
ClinConnect Summary
This clinical trial is studying how people think and feel about nicotine products, like cigarettes and e-cigarettes, especially focusing on young adults who might consider using these products and adults who already use them. The researchers want to understand how different claims about these products influence people's opinions and behaviors. They are currently looking for participants aged 18 to 65 who either have never used nicotine products but might be tempted to, or are current users of tobacco products, whether they smoke or use other forms like vaping.
If you're eligible to participate, you would need to come to an in-person lab visit where you’ll share your thoughts and feelings about nicotine products. This study is important because it aims to help us understand how advertising or claims about these products can impact people’s choices, which could lead to better health strategies in the future.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- * Young adult susceptible non-users aged 18-24 who have never used ONPs and have never used but are susceptible to using either:
- • combustible tobacco only (cigarettes, cigars, waterpipe)
- • non-combustible tobacco only (ST, ECs, heated tobacco products)
- • or both combustible and non-combustible tobacco (i.e., dual susceptibility)
- * Adult tobacco users aged 18-65 who have never used ONPs OR have used ONPs \>3 months ago and 10 times or less in their lifetime. All adult tobacco users must also be:
- • exclusive combustible tobacco users
- • exclusive non-combustible tobacco users
- • dual users
- • For adult tobacco users, we will define current use as use of combustible and/or non-combustible tobacco every day or some days for 6 months or longer
- • Willing and able to complete an in-person lab visit.
- Exclusion Criteria:
- • Age \< 18 or \> 65
- • Are not susceptible non-users or current tobacco users
- • Are unwilling or unable to complete and in person lab visit.
- • Have used ONPs within the past 3 months
- • Have used ONPs more than 10 times in their lifetime
About Ohio State University Comprehensive Cancer Center
The Ohio State University Comprehensive Cancer Center (OSUCCC) is a leading institution dedicated to advancing cancer research, treatment, and education. As a National Cancer Institute-designated comprehensive cancer center, OSUCCC integrates cutting-edge research with clinical practice to develop innovative therapies and improve patient outcomes. With a collaborative approach that unites scientists and clinicians, OSUCCC focuses on personalized medicine, cancer prevention, and community outreach, striving to enhance the understanding of cancer biology and provide hope to patients through groundbreaking clinical trials and comprehensive care programs.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Columbus, Ohio, United States
Patients applied
Trial Officials
Darren Mays, MPH, PhD
Principal Investigator
Ohio State University Comprehensive Cancer Center
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported